Impact of Computerized Physician Order Entry on Medication Prescription Errors in the Intensive Care Unit: a Controlled Cross-Sectional Trial.

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00287274
First received: February 2, 2006
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Device: computerized physician order entry.

We wanted to investigate if the introduction of a computerized intensive care unit system reduced the incidence and severity of medication prescription errors (MPEs). A prospective trial was conducted during 5 weeks in a paper-based unit versus a computerized unit. The registration of different classes of MPEs was done by a clinical pharmacist. An independent panel evaluated the severity of MPEs.


Condition Intervention
Medication Errors
Patient Safety
Device: computerized physician order entry

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Impact of Computerized Physician Order Entry on Medication Prescription Errors in the Intensive Care Unit: a Controlled Cross-Sectional Trial.

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • To compare the the incidence and severity of medication prescription errors between a CPOE unit and a paper-based unit at completion of the study.

Secondary Outcome Measures:
  • Description of MPEs in both units at completion of the study.

Estimated Enrollment: 160
Study Start Date: March 2004
Study Completion Date: April 2004
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients admitted to the Surgical Intensive Care Unit

Exclusion Criteria:

  • Adult Patients admitted to other units
  • Pediatric patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00287274

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Kirsten Colpaert, MD University Hospital, Ghent
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00287274     History of Changes
Other Study ID Numbers: 2004/002
Study First Received: February 2, 2006
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on September 18, 2014